The Nepal authorities has not officially responded to the Chinese decision but. Though the Nepal authorities granted approval for emergency use of the vaccine developed by China's Sinopharm on February 18, the dearth of proper documentation of its trial results and logistic issues has prevented its rollout for larger public
